Brief: Zynerba Pharmaceuticals - On May 2 Nasdaq Notified Co It Granted Co Additional 180 Calendar Day Period To Regain Compliance With Bid Price Rule
04/05/2023 22:12
May 4 (Reuters) - Zynerba Pharmaceuticals Inc ZYNE.O :
* ZYNERBA PHARMACEUTICALS - ON MAY 2 NASDAQ NOTIFIED CO IT
GRANTED
CO ADDITIONAL 180 CALENDAR DAY PERIOD TO REGAIN COMPLIANCE WITH
BID PRICE RULE
* ZYNERBA PHARMACEUTICALS INC - ON MAY 2, 2023, NASDAQ
APPROVED
COMPANY'S TRANSFER FROM NASDAQ GLOBAL MARKET TO NASDAQ CAPITAL
MARKET
* ZYNERBA PHARMACEUTICALS INC - COMMON STOCK WILL CONTINUE
TO
TRADE UNDER SYMBOL "ZYNE."
Further company coverage: ZYNE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Zynerba Pharmaceuticals
See all newsBrief: Harmony Biosciences Completes Acquisition Of Zynerba Pharmaceuticals
Brief: Harmony Biosciences Announces Extension Of Tender Offer To Acquire Zynerba Pharmaceuticals, Inc.
Brief: Zynerba Pharmaceuticals Presents Positive Data From Phase 2 Inspire Trial
U.S. RESEARCH ROUNDUP-Easterly Government Properties, Visa, Zynerba Pharmaceuticals
Zynerba Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary